SCHEMBL5820194

SCHEMBL5820194

O=S(=O)(Nc1ccc2cc[nH]c2c1)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.74
HTR6 P50406 2/20 0.74
CYP19A1 P11511 2/20 0.74
LMNA P02545 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
ALDH1A1 P00352 3/20 0.62
MEN1 O00255 1/20 0.53
PKM P14618 1/20 0.53
KMT2A Q03164 1/20 0.53
IL1RN P18510 1/20 0.51
KEAP1 Q14145 1/20 0.51
ERAP1 Q9NZ08 1/20 0.51
HPGD P15428 1/20 0.51
BRD4 O60885 1/20 0.50
PIK3CA P42336 1/20 0.50
IMPDH2 P12268 1/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
HDAC3 O15379 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2510834 0.88 CYP19A1 (0.64) ESR1HTR6CYP19A1LMNASMN1; SMN2
SCHEMBL16719331 0.88 ESR1 (0.78) ESR1HTR6CYP19A1LMNASMN1; SMN2
SCHEMBL4881882 0.86 ESR1 (0.76) ESR1HTR6CYP19A1LMNASMN1; SMN2
SCHEMBL517779 0.85 ESR1 (0.62) ESR1HTR6CYP19A1SMN1; SMN2ALDH1A1
SCHEMBL16719591 0.85 ESR1 (0.62) ESR1HTR6CYP19A1ALDH1A1PKM
SCHEMBL3037102 0.82 ESR1 (0.80) ESR1HTR6CYP19A1MEN1KMT2A
SCHEMBL7137662 0.78 MEN1 (0.66) ESR1HTR6CYP19A1MEN1KMT2A
SCHEMBL18553762 0.78 ESR1 (0.64) ESR1HTR6CYP19A1LMNAALDH1A1
SCHEMBL1607103 0.78 PIP4K2A (0.64) ESR1HTR6CYP19A1HDAC3HDAC4
SCHEMBL2614387 0.77 SMN1; SMN2 (1.00) HTR6LMNASMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651595-A2 UBIQUITIN LIGASE INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2006-05-03 EP claimed
WO-2005007621-A2 UBIQUITIN LIGASE INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2005-01-27 WO claimed
US-6723726-B1 Protein tyrosine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2004-04-20 US disclosed
EP-1304110-A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LIMITED (GB) 2003-04-23 EP disclosed